263 results on '"AHERNE, W."'
Search Results
2. A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D
3. A prospective, blinded analysis of thymidylate synthase and p53 expression as prognostic markers in the adjuvant treatment of colorectal cancer
4. Quantative morphology
5. Metabolism, excretion and pharmacokinetics of a single dose of [14C]-raltitrexed in cancer patients
6. Sudden And Unexpected Deaths In Infants: Histology And Virology
7. Deaths Associated With Respiratory Tract Infection In Childhood
8. Interference by antifolate drugs in a folate competitive protein-binding assay
9. A reappraisal of the stathmokinetic technique: II. Metaphase degeneration and its correction
10. PHOTOGRAPHIC SCREENING PROCEDURE FOR TRIAZINE HERBICIDES IN WATER USING AN ENHANCED LUMINESCENT IMMUNOASSAY
11. Serum angiogenic profile of patients with glioblastoma identifies distinct tumor subtypes and shows that TIMP-1 is a prognostic factor
12. See How They Run
13. 149 POSTER Acetylation of molecular chaperones by histone deactylase inhibitors (HDACI)
14. 350 POSTER Measurement of mechanistic markers of histone deacetylase (HDAC) inhibition in samples from clinical trials
15. 4,5 Diaryl Isoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer
16. A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D
17. A first-in-man phase I study of R306465, a histone deacetylase (HDAC) inhibitor exploring pharmacokinetics (PK) and pharmacodynamics (PD) utilizing an electrochemiluminescent immunoassay in patients (p) with advanced tumours
18. Inhibition of the HSP90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole, isoxazole amide analogs
19. 375 POSTER Downstream mechanistic markers of HDAC inhibition for drug discovery and clinical evaluation
20. 426 POSTER A high throughput screen and secondary assays for the identification and evaluation of histone methyltransferase inhibitors
21. A phase I pharmacokinetic and pharmacodynamic study of BGC9331 and carboplatin in relapsed gynaecological malignancies
22. A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points
23. Effects of the histone deacetylase inhibitor (HDACI) LAQ824 on histone acetylation, Hsp70 and c-Raf in peripheral blood lymphocytes from patients with advanced solid tumours enrolled in a phase I clinical trial
24. Human Hsp90-alpha with 8-(2-chloro-3,4,5-trimethoxy-benzyl)-9-pent-4-ylnyl-9H-purin-6-ylamine
25. Human Hsp90-alpha with 8-(2-chloro-3,4,5-trimethoxy-benzyl)-2-fluoro-9-pent-4-ylnyl-9H-purin-6-ylamine
26. Human Hsp90-alpha with 9-Butyl-8-(2,5-dimethoxy-benzyl)-2-fluoro-9H-purin-6-ylamine
27. Metabolism, excretion and pharmacokinetics of a single dose of [ 14 C]-raltitrexed in cancer patients
28. Reply
29. Development of an enzyme-linked immunosorbent assay for isoproturon in water
30. Histologic, pharmacologic, and immunocytochemical effects of injection of bleomycin into viral warts
31. The effects of dexamethasone on the cell kinetics of a murine malignant lymphoma.
32. SPINAL CORD INJURY OF THE FETUS DURING DELIVERY WITH KIELLAND'S FORCEPS.
33. The estimation of neuronal population density by a robust distance method.
34. A reappraisal of the stathmokinetic technique.
35. Macrophage infiltration of breast tumours: a prospective study.
36. Assessment of inherent fluctuations of mitotic and labelling indices of human tumours.
37. Brown adipose tissue and heat production in the newborn infant.
38. Quantitative aspects of placental structure.
39. A case of primary sarcoma of heart with vertebral metastases.
40. MORPHOMETRY OF THE HUMAN PLACENT.
41. Familia neuroblastoma: report of two sib pairs.
42. FAT INFILTRATION IN THE TISSUES OF THE NEWBORN INFANT.
43. The Placental Transfusion Syndrome in Monozygous Twins.
44. Congenital pneumonia.
45. A case of osteopetrosis (Albers-Schonberg) with intercurrent Pneumocystis pneumonitis.
46. Genetics.
47. A FAMILIAL FEMINIZING SYNDROME.
48. Pathological changes in virus infections of the lower respiratory tract in children.
49. THE DIFFERENTIATION OF MYELOMATOSIS FROM OTHER CAUSES OF BONE MARROW PLASMACYTOSIS.
50. The “Burr” Red Cell and Azotaemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.